Cite
Portland Intensive Insulin Therapy During Living Donor Liver Transplantation: Association with Postreperfusion Hyperglycemia and Clinical Outcomes
MLA
Justin Sangwook Ko, et al. “Portland Intensive Insulin Therapy During Living Donor Liver Transplantation: Association with Postreperfusion Hyperglycemia and Clinical Outcomes.” Scientific Reports, vol. 8, no. 1, Feb. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ab67b6253549d672daa57625efcdbb21&authtype=sso&custid=ns315887.
APA
Justin Sangwook Ko, Gaab Soo Kim, RyungA Kang, Mi Sook Gwak, Kyo Won Lee, Soo Joo Choi, Sangbin Han, & Sang Hyun Lee. (2018). Portland Intensive Insulin Therapy During Living Donor Liver Transplantation: Association with Postreperfusion Hyperglycemia and Clinical Outcomes. Scientific Reports, 8(1).
Chicago
Justin Sangwook Ko, Gaab Soo Kim, RyungA Kang, Mi Sook Gwak, Kyo Won Lee, Soo Joo Choi, Sangbin Han, and Sang Hyun Lee. 2018. “Portland Intensive Insulin Therapy During Living Donor Liver Transplantation: Association with Postreperfusion Hyperglycemia and Clinical Outcomes.” Scientific Reports 8 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ab67b6253549d672daa57625efcdbb21&authtype=sso&custid=ns315887.